Orthostatic hypotension is also called postural hypotension. It occurs when a patient’s blood pressure decreases while standing up or sitting down. Orthostatic hypotension can be defined as fall in systolic blood pressure by at least 20mm Hg or fall in diastolic blood pressure by at least 10mm Hg while standing up or lying down. Postural hypotension can make a person feel light headed, dizzy, and even faint. Orthostatic hypotension is caused due to various reasons such as dehydration, heart problems, endocrine problems, and nervous systems disorders. The person suffering from this disorder can be at risk of fainting, stroke, or cardiovascular diseases.
The global orthostatic hypotension market is expect to expand at a significant CAGR during the forecast period. Orthostatic hypotension is considered one of the common cardiovascular diseases, underlying neurodegenerative disorders. According to the Journal of the American College of Cardiology, prevalence of orthostatic hypotension is between 5% and 30%, globally. This is one key factor driving the global orthostatic hypotension market. Rise in geriatric population and unhealthy lifestyle such as alcoholism are attributed to the growth of the global market. Furthermore, prevalence of certain chronic diseases such as diabetes, medication such as antipsychotics, and relaxants that increase the risk of orthostatic hypotension are factors likely to propel the global market during the forecast period. Side effects of the treatment and lack of awareness among the people toward the disorder in developing countries are factors restraining the global orthostatic hypotension market.
The global orthostatic hypotension market can be segmented based on drug class, diagnostic test, end-user, and region. In terms of drug class, the global orthostatic hypotension market can be divided Fludrocortisone, midodrine, indomethacin, NSAIDs, oxilofrine, and others. Based on diagnostic test, the global market can be categorized into blood tests, stress tests, ECG, and others. In terms of end-user, the global orthostatic market can be segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment is expected to register significant growth due to increase in number of hospitals and health care expenditure.
Geographically, the global orthostatic hypotension market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the market, accounting for the largest share. Increase in prevalence of obesity in young adults and children leading to orthostatic hypotension is one of the major factors driving the market in the region. Furthermore, advanced technology, rise in awareness among people toward diagnosis of the disorders, high health care expenditure, and availability of the drugs are some of the factors attributed to the growth of the orthostatic hypotension market in North America. Europe is also anticipated to account for a significant share of the global market. Factors attributed to the growth of the market in the region are increase in geriatric population and rise in health care expenditure. The market in Asia Pacific is anticipated to register faster growth rate during the forecast period. Asia Pacific is the most lucrative market due to rising geriatric population, adoption of health care solutions for better standard of life, rise in awareness about health, prevalence of lifestyle related diseases, and high investment in health care sector.
Key players in the global orthostatic hypotension market have adopted strategies such as mergers, acquisitions, cost effective and efficient drugs, and collaborative partnerships to gain leadership position. Major players operating in the global orthostatic hypotension market are H. Lundbeck A/S, Amgen, Inc., Shire plc, and Hoffmann-La Roche Limited, among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.